يعرض 1 - 10 نتائج من 69 نتيجة بحث عن '"Dominique Valade"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Centre Hospitalier Universitaire de Nice (CHU Nice), Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Lille, Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Rouen, Normandie Université (NU), Service de neurochirurgie [CHU Rouen], Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Hôpital Foch [Suresnes], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], CH Colmar, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de Neurochirurgie [CHU Limoges], CHU Limoges, Service de Neurochirurgie [CHU Poitiers], Centre hospitalier universitaire de Poitiers (CHU Poitiers), Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Medtronic, Centre Hospitalier Universitaire de Nice, Source(s) of financial support: This work has been developed and supported by the Centre Hospitalier Universitaire de Nice through the FHU INOVPAIN consortium (Nice). St Jude Medical‐Abbott and Medtronic have partially supported the study financially but had no role in the study design, data collection, analysis, and reporting., Dr. Fontaine and Dr. Lanteri‐Minet received consultant fees and research grants from Medtronic. Dr. Chabardes and Dr. Derrey have been consultants for Medtronic. Dr. Voirin received consultant fees from Medtronic. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Dr. Fontaine and Dr. Lanteri‐Minet received consultant fees and research grants from St. Jude‐Abbott. Dr. Chabardes has been a consultant for Boston Scientific. Dr. Raoul is a consultant for Abbott and Boston Scientific. Dr. Voirin and Dr. Fontaine received consultant fees from Boston Scientific. Dr. Lucas has participated on an advisory board with Novartis, Lilly, Amgen, Lundbeck, AbbVie, and TEVA. Dr. Lucas has also served on a speakers' bureau or participated in educational events with Novartis, Teva and Lilly. Dr. Donnet has received consulting fees from Novartis, TEVA, Amgen, and Lilly. Dr. Donnet has also served on a speakers' bureau or participated in educational events with Novartis. These three companies manufacture and commercialize neuromodulation devices that can be used for ONS. Conflict of Interest, Service de Neurochirurgie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Service de Neurochirurgie [Poitiers]

    المصدر: Neuromodulation
    Neuromodulation, 2021, 24 (6), pp.1083-1092. ⟨10.1111/ner.13394⟩
    Neuromodulation, Wiley, 2021, 24 (6), pp.1083-1092. ⟨10.1111/ner.13394⟩

  4. 4

    المساهمون: Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)

    المصدر: Neurosurgery
    Neurosurgery, Lippincott, Williams & Wilkins, 2021, 88 (2), pp.375-383. ⟨10.1093/neuros/nyaa373⟩

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    المساهمون: Département de neurologie [Montpellier], Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Gui de Chauliac [CHU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université de Montpellier (UM), Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Hôpital Gui de Chauliac [Montpellier]-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université Montpellier 1 (UM1)-Université de Montpellier (UM), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Gui de Chauliac [Montpellier]-Université de Montpellier (UM)

    المصدر: Revue Neurologique
    Revue Neurologique, 2017, 173 (3), pp.131-151. ⟨10.1016/j.neurol.2016.12.033⟩
    Revue Neurologique, Elsevier Masson, 2017, 173 (3), pp.131-151. ⟨10.1016/j.neurol.2016.12.033⟩

  10. 10